436 related articles for article (PubMed ID: 18644385)
1. Hepatitis B in a high prevalence New Zealand population: a mathematical model applied to infection control policy.
Thornley S; Bullen C; Roberts M
J Theor Biol; 2008 Oct; 254(3):599-603. PubMed ID: 18644385
[TBL] [Abstract][Full Text] [Related]
2. A mathematical model to estimate global hepatitis B disease burden and vaccination impact.
Goldstein ST; Zhou F; Hadler SC; Bell BP; Mast EE; Margolis HS
Int J Epidemiol; 2005 Dec; 34(6):1329-39. PubMed ID: 16249217
[TBL] [Abstract][Full Text] [Related]
3. Impact of routine hepatitis B immunization on the prevalence of chronic hepatitis B virus infection in the marshall islands and the federated States of micronesia.
Bialek SR; Helgenberger L; Fischer GE; Bower WA; Konelios M; Chaine JP; Armstrong G; Williams IT; Bell BP
Pediatr Infect Dis J; 2010 Jan; 29(1):18-22. PubMed ID: 19841605
[TBL] [Abstract][Full Text] [Related]
4. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
5. Progress in hepatitis B prevention through universal infant vaccination--China, 1997-2006.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2007 May; 56(18):441-5. PubMed ID: 17495790
[TBL] [Abstract][Full Text] [Related]
6. A mathematical model of hepatitis B virus transmission and its application for vaccination strategy in china.
Zhao S; Xu Z; Lu Y
Int J Epidemiol; 2000 Aug; 29(4):744-52. PubMed ID: 10922354
[TBL] [Abstract][Full Text] [Related]
7. Demography and presentation of chronic hepatitis B virus infection.
Heathcote EJ
Am J Med; 2008 Dec; 121(12 Suppl):S3-11. PubMed ID: 19185072
[TBL] [Abstract][Full Text] [Related]
8. Modelling the epidemiology of hepatitis B in New Zealand.
Mann J; Roberts M
J Theor Biol; 2011 Jan; 269(1):266-72. PubMed ID: 21040731
[TBL] [Abstract][Full Text] [Related]
9. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
10. Acute hepatitis B 14 years after the implementation of universal vaccination in Italy: areas of improvement and emerging challenges.
Mele A; Tosti ME; Mariano A; Pizzuti R; Ferro A; Borrini B; Zotti C; Lopalco P; Curtale F; Balocchini E; Spada E;
Clin Infect Dis; 2008 Mar; 46(6):868-75. PubMed ID: 18269332
[TBL] [Abstract][Full Text] [Related]
11. Incidence and routes of transmission of hepatitis B virus in England and Wales, 1995-2000: implications for immunisation policy.
Hahné S; Ramsay M; Balogun K; Edmunds WJ; Mortimer P
J Clin Virol; 2004 Apr; 29(4):211-20. PubMed ID: 15018847
[TBL] [Abstract][Full Text] [Related]
12. High impact of migration on the prevalence of chronic hepatitis B in the Netherlands.
Marschall T; Kretzschmar M; Mangen MJ; Schalm S
Eur J Gastroenterol Hepatol; 2008 Dec; 20(12):1214-25. PubMed ID: 18946359
[TBL] [Abstract][Full Text] [Related]
13. [Hepatitis B vaccination in France: vaccination coverage in 2002].
Denis F
Bull Acad Natl Med; 2004; 188(1):115-23. PubMed ID: 15368931
[TBL] [Abstract][Full Text] [Related]
14. Long-term vaccination decreasing HBV in the Gambia.
Vaccine Wkly; 1995 May; ():8-9. PubMed ID: 12346215
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B vaccine: clinical experience.
Tron F
IARC Sci Publ; 1984; (63):279-95. PubMed ID: 6242147
[TBL] [Abstract][Full Text] [Related]
16. Forecasting the declining rate of chronic hepatitis-B carrier status at a Taiwanese university: twenty years after implementation of an universal HBV vaccination program in Taiwan.
Su FH; Huang HY; Chang HJ; Jeng JJ; Liu YH; Chen CD
Chang Gung Med J; 2007; 30(6):521-8. PubMed ID: 18350735
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of hepatitis B virus infection among the tribes of Andaman and Nicobar Islands, India.
Murhekar MV; Murhekar KM; Sehgal SC
Trans R Soc Trop Med Hyg; 2008 Aug; 102(8):729-34. PubMed ID: 18565560
[TBL] [Abstract][Full Text] [Related]
18. Public health management of perinatal hepatitis B virus.
Libbus MK; Phillips LM
Public Health Nurs; 2009; 26(4):353-61. PubMed ID: 19573214
[TBL] [Abstract][Full Text] [Related]
19. [WHO spearheads global initiative to eradicate hepatitis B].
Sylvan S
Lakartidningen; 2000 Aug; 97(35):3738-40. PubMed ID: 11016226
[TBL] [Abstract][Full Text] [Related]
20. Model based analysis of hepatitis B vaccination strategies in the Netherlands.
Kretzschmar M; Mangen MJ; van de Laar M; de Wit A
Vaccine; 2009 Feb; 27(8):1254-60. PubMed ID: 19118594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
